We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Higher Field Strengths and New Clinical Applications Increase Growth of MRI Systems

By MedImaging staff writers
Posted on 27 Jun 2007
Print article
Magnetic resonance imaging (MRI) is one of the most powerful and widely used diagnostic tools by clinicians today. However, there are many challenges such as increasing pricing pressures, regulatory issues, and competition from computed tomography (CT) that need to be overcome in the European MRI systems market, according to a recent marketing report.

Despite these challenges, the market is expected to see growth. The scope for growth is related to the introduction of new applications. The market is not yet saturated and there are a few unexplored niche segments, which offer huge growth potential. Frost & Sullivan (Palo Alto, CA, USA), an international growth consultancy company, found that the European MRI market earned revenues of US$806.5 million in 2006 and estimates this to reach $1.03 billion in 2013.

"The European MRI systems market is primarily driven by the current wide variety of applications and constant development of new ones,” noted Frost & Sullivan research analyst B. Divya. "With continued upgrades in Tesla strength, the number of applications using MRI is increasing from the research point of view and is also becoming increasingly commercially viable.”

With advancements in neurologic, cardiac, and vascular, as well as breast MRI, the market is seeing growth essentially due to the application potential. Each new clinical application increases the usage of MRI systems. Moreover, high-field systems are expected to continue demonstrating strong growth, thereby replacing low-field systems.

However, the current state of the European healthcare system is restraining market growth. In addition, differing reimbursement policies in various geographic regions in the European Union are still another challenge. Furthermore, there is also the inherent challenge arising due to competition from CT.

"The European healthcare industry is experiencing severe financial constraints from having to support an aging population, with contributions from a small portion of working population,” explained Ms. Divya. "Consequently, the governments of various nations are wary of the fact that healthcare spending is exceedingly high, and one of the interesting ways in which nations are reducing healthcare costs is by simply not buying additional equipment.”

As the market is heading toward saturation, market participants will need to concentrate on niche segments. Targeting niche markets can be either through the acquisition of existing small local participants or through the introduction of new products.


Related Links:
Frost & Sullivan
Ultrasonic Pocket Doppler
SD1
New
High-Precision QA Tool
DEXA Phantom
New
Pocket Fetal Doppler
CONTEC10C/CL
Ultrasound Table
Women’s Ultrasound EA Table

Print article

Channels

Radiography

view channel
Image: The new machine algorithm can identify cardiovascular risk at the click of a button (Photo courtesy of Adobe Stock)

Machine Learning Algorithm Identifies Cardiovascular Risk from Routine Bone Density Scans

A new study published in the Journal of Bone and Mineral Research reveals that an automated machine learning program can predict the risk of cardiovascular events and falls or fractures by analyzing bone... Read more

MRI

view channel
Image: In brains of control mice (left) and PD mice (right), from bottom to top: neuronal activity in a representative animal (Photo courtesy of Ruxanda Lungu/FC)

Simple Brain Scan Diagnoses Parkinson's Disease Years Before It Becomes Untreatable

Parkinson's disease (PD) remains a challenging condition to treat, with no known cure. Though therapies have improved over time, and ongoing research focuses on methods to slow or alter the disease’s progression,... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.